Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

By: via Benzinga
Catalyst Biosciences Inc(NASDAQ: CBIO) hasagreed to sellits portfolio of protease medicines that regulate ...
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.